LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - Roivant (NASDAQ: ROIV)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ROIV Roivant
Pulik Richard / officer: CFO
08/28/2024
Sell
$12.00
2,341
$28K
285,752
NASDAQ ROIV Roivant
Kumar Rakhi / officer: Chief Accounting Officer
08/20/2024
Sell
$11.48
958
$11K
212,409
NASDAQ ROIV Roivant
Venker Eric / officer: President & COO
08/20/2024
Sell
$11.48
10,947
$126K
639,360
NASDAQ ROIV Roivant
Gline Matthew / director, officer: CEO
08/20/2024
Sell
$11.48
10,947
$126K
18.31M
NASDAQ ROIV Roivant
Venker Eric / officer: President & COO
07/26/2024
Buy
$10.80
409,000
$4.417M
409,000
NASDAQ ROIV Roivant
Pulik Richard / officer: CFO
07/28/2024
Sell
$10.80
2,341
$25K
288,093
NASDAQ ROIV Roivant
Gline Matthew / director, officer: CEO
07/20/2024
Sell
$11.00
10,945
$120K
1.12M
NASDAQ ROIV Roivant
Venker Eric / officer: President & COO
07/20/2024
Sell
$11.00
10,945
$120K
446,307
NASDAQ ROIV Roivant
Kumar Rakhi / officer: Chief Accounting Officer
07/20/2024
Sell
$11.00
958
$11K
213,367
NASDAQ ROIV Roivant
Oren Ilan / director
07/23/2024
Sell
$11.01
215
$2K
82,634

COPYRIGHT ©2023 HEALTH STOCKS HUB